Comment on: “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments”-Reference-Cited by-同舟云学术

Comment on: “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments”

Published:2019-09-24 Issue:12 Volume:42 Page:1515-1516
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Jandhyala Ravi^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s40264-019-00862-x.pdf

Reference9 articles.

1. McGettigan P, Alonso Olmo C, Plueschke K, Castillon M, Nogueras Zondag D, Bahri P, et al. Patient Registries: an underused resource for medicines evaluation: operational proposals for increasing the use of patient registries in regulatory assessments. Drug Saf. 2019. https://doi.org/10.1007/s40264-019-00848-9 (Epub 13 Jul 2019).

2. Barnett-Page E, Thomas J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol. 2009;9:59. https://doi.org/10.1186/1471-2288-9-59 .

3. Gliklich R, Dreyer N. Registries for evaluating patient outcomes: a user’s guide. Agency for Healthcare Research and Quality; 2007.

4. Zaletel M, Kralj M. Methodological guidelines and recommendations for efficient and rational governance of patient registries. PARENT. 2015;25:232.

5. European Medicines Agency. Patient Registries. http://www.ema.europa.eu/ema/index.jsp%3fcurl%3dpages/regulation/general/general_content_000658.jsp%26mid%3dWC0b01ac0580961211 . Accessed 12 Aug 2019.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of adding real-world evidence to regulatory submissions on the breadth of population indicated for rare disease medicine treatment by the European Medicines Agency;Journal of Pharmaceutical Policy and Practice;2022-05-04

2. Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument;Health and Quality of Life Outcomes;2021-09-28

3. The multiple stakeholder approach to real-world evidence (RWE) generation: observing multidisciplinary expert consensus on quality indicators of rare disease patient registries (RDRs);Current Medical Research and Opinion;2021-05-21

4. The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study;Orphanet Journal of Rare Diseases;2020-06-30

5. Factors Influencing the Generation of Evidence from Simple Data Held in International Rare Disease Patient Registries;Pharmaceutical Medicine;2019-12-05